Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Preferred Stock Liabilities: 2016-2024

Historic Preferred Stock Liabilities for Organogenesis Holdings (ORGO) over the last 3 years, with Dec 2024 value amounting to $122.4 million.

  • Organogenesis Holdings' Preferred Stock Liabilities was N/A to $130.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.9 million, marking a year-over-year change of. This contributed to the annual value of $122.4 million for FY2024, which is N/A change from last year.
  • Organogenesis Holdings' Preferred Stock Liabilities amounted to $122.4 million in FY2024, which was up 1,710.40% from $6.8 million recorded in FY2017.
  • Over the past 5 years, Organogenesis Holdings' Preferred Stock Liabilities peaked at $122.4 million during FY2024, and registered a low of $122.4 million during FY2024.
  • Its 1-year average for Preferred Stock Liabilities is $122.4 million, with a median of $122.4 million in 2024.